"Ning Wang" fell by more than 9%.The market capitalization has lost nearly 120 billion.

"Ningwang" fell nearly 10% in morning trading. By the end of the day, it closed down 8.88%, the share price fell to 528 yuan per share, and the market value lost nearly 120 billion to 1.23 trillion yuan. The transaction volume reached 7.6 billion.

Chip giant and Apple chain leader both fell by nearly 10%.Gem plummeted by more than 4%

Not only the "King of Ning" plummeted, but also the leaders of the major plates plummeted collectively. North Huachuang, the leader of 100 billion chips, fell nearly 10%.

300 billion Apple Inc chain leader Lixun Precision fell nearly 10%.

Enjie shares, Yiwei LiNeng, etc., continued to decline, down more than 7%; Sunshine Power, Changchuan Technology, San'an Optoelectronics, Shilanwei, Zhaoyi Innovation and so on followed the decline.

So far, the gem fell below 2800 points, closing down 4.27%.

Added to the "unverified list" by the U.S. Department of Commerce.A shares fell by the limit, and Hong Kong stocks fell 30% at one point and were urgently suspended!

Of course, the biggest news in this morning's trading, the pharmaceutical giant "Yao Ming" fell sharply.

Wuxi Biologics, which is listed in Hong Kong, fell more than 30 per cent at one point, then suspended trading close to 11:00 and fell nearly 23 per cent before the suspension to HK $62.25, with a market capitalization of HK $262.4 billion.

Wuxi Apptec, which is listed on the A-share market, opened with a flash drop, with the latest share price of 94.05 yuan per share, with a market capitalization of 270.1 billion yuan.

Wuxi Apptec, which is listed in Hong Kong, fell more than 20 per cent at one point and closed down more than 15 per cent by midday.

The sudden collapse stems from a sudden piece of news in the United States.

The US government on the 7th put 33 Chinese entities on the Department of Commerce's "unverified list" (Unverified List), imposed new restrictions on these entities' access to products from US exporters, and required additional investigations by US companies that want to do business with these Chinese companies.

In this "unverified list (UVL)", CDMO company Wuxi Biologics and Wuxi Biologics (Shanghai) are included. Public data show that Wuxi Apptec and Wuxi Biologics both belong to the same actual controller.

According to Wuxi Biologics's latest revenue structure, the United States accounts for nearly 50% of revenue, while China accounts for only 26.35%, which is extremely dependent on overseas markets.

After the news came out, the shares of "Yao Ming" fell sharply. Not only that, CXO plate plummeted across the board. Pharmaron Beijing Co., Ltd.* is down 10% and Tigermed is down 9%.

Response: not "entity list"」Or "blacklist."The impact is negligible

In response to being included in the Commerce Department's "unverified list", Wuxi Biologics said: we understand that the reason for this action is that US government agencies have failed to carry out the necessary end-use verification to export some equipment from US suppliers. The "unverified list" is not the more familiar "entity list" or "blacklist" of the United States.

Wuxi Biologics has been importing some hardware controllers of bioreactors and some hollow fiber filters for the past 10 years, which are subject to US export controls but have been approved by the US Department of Commerce. We comply with all US export control regulations. We will not re-export or resell these items to any other entity Ministry of Commerce has a set of routine procedures to verify whether these items can be properly used on the site (that is, for self-use, not for resale). This process has not been completed in the past two years due to the 2019 coronavirus pandemic.

This will not affect our business or our ongoing services to our global partners. This has little impact on our imports because such equipment is not needed after the construction of factories in Shanghai and Wuxi. We are welcome to check at any time in order to remove it from such a list. We are also taking interim measures to remove these subsidiaries from the list prior to inspection.

Meanwhile, according to the Hong Kong Economic Daily, Wuxi Biologics executives mentioned in a conference call with CITIC Construction Investment Corporation this morning that companies on the list of unverified entities (UVL) can take relevant measures to seek removal from the list, mainly by the company's own commitment (the relevant export control products are for self-use, not for resale) or waiting for inspection by the US Department of Commerce. At present, the company's team of lawyers in the United States is working urgently to prepare for negotiations with the U.S. Department of Commerce tomorrow.

Nearly 190000 shareholders are confused.Or Glenn's first heavy stock.

According to wind data, as of the end of the third quarter, Wuxi Apptec, which is listed on A shares, has 187000 shareholder households.

And Glenn's China Europe Medical and Health is the most important stock is Wuxi Apptec. According to the four Seasons report of the Fund, from the perspective of positions, the ranking of CEIBS Healthcare compared to the top five major stocks in the third quarter of 2021 has not changed, and their holdings have increased. Among them, the largest heavy stock of the fund is Wuxi Apptec, which increased its stake in Wuxi Apptec by 24.8067 million shares to 65.7161 million shares in the fourth quarter, and its position rose to 10.05%.

Liquor plummeted.Guizhou Moutai once fell by more than 4%.

Not only that, the "drinking" market is also fierce.

Guizhou Moutai fell more than 4% at one point, closing down 3.64%, with a share price of 1800 yuan and a market capitalization of 2.26 trillion yuan.

In addition, Yingjia tribute wine and Gujing tribute wine fell by more than 6%, Shuijingfang and Wuliangye fell by nearly 5%, Shanxi Fenjiu and Luzhou laojiao all the way down.